Abstract | AIMS: To examine the tumor-forming in nude mice of human epithelial cells co-expressed Bcl-2 and EBV LMP-1 ability, the phenotype of tumor cells and their expression of oncogenes and tumor-suppressor genes. METHODS: Following an in vivo tumorigenesis test in nude mice, the phenotype and growth properties of tumor cells were observed. Levels of expression of Bcl-2, and EBV LMP-1, and of onco- and tumor-suppressor proteins were detected by Western blot assay. RESULTS: Human epithelial cells co-expressing Bcl-2 and EBV LMP-1 can form tumors in nude mice. Tumors appeared 48-65 days postinoculation in 6 of 10 nude mice tested but not in mice given Bcl-2-positive (0/5), LMP-1-positive (0/5) and RHEK-1 control (0/5) cells. Levels of c-myc protein were upregulated by LMP-1 but were not affected by Bcl-2 in this cell background; screening for other cellular oncogene and tumor suppressor gene products showed no change. CONCLUSION: The complementary effects of EBV LMP-1 and Bcl-2 in human epithelial cells resulted in tumor formation in nude mice but did not affect the expression of onco- and tumor suppressor proteins except for elevated c-myc. These findings suggest that LMP-1 and Bcl-2 can contribute together to the formation of EBV-associated epithelial cell tumors.
|
Authors | John Jenn-Yenn Lu, Jong-Ding Lay |
Journal | Intervirology
(Intervirology)
Vol. 50
Issue 6
Pg. 454-60
( 2007)
ISSN: 1423-0100 [Electronic] Switzerland |
PMID | 18268409
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | (c) 2008 S. Karger AG, Basel |
Chemical References |
- EBV-associated membrane antigen, Epstein-Barr virus
- Proto-Oncogene Proteins c-bcl-2
- Viral Matrix Proteins
|
Topics |
- Animals
- Epithelial Cells
(metabolism, pathology, virology)
- Epstein-Barr Virus Infections
(physiopathology, virology)
- Genes, bcl-2
- Herpesvirus 4, Human
(pathogenicity)
- Humans
- Mice
- Mice, Nude
- Proto-Oncogene Proteins c-bcl-2
(genetics, metabolism)
- Tumor Virus Infections
- Viral Matrix Proteins
(metabolism)
|